These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14699093)

  • 1. Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells.
    Rossignol P; Ho-Tin-Noé B; Vranckx R; Bouton MC; Meilhac O; Lijnen HR; Guillin MC; Michel JB; Anglés-Cano E
    J Biol Chem; 2004 Mar; 279(11):10346-56. PubMed ID: 14699093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein.
    Kasza A; Petersen HH; Heegaard CW; Oka K; Christensen A; Dubin A; Chan L; Andreasen PA
    Eur J Biochem; 1997 Sep; 248(2):270-81. PubMed ID: 9346278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin.
    Eaton DL; Scott RW; Baker JB
    J Biol Chem; 1984 May; 259(10):6241-7. PubMed ID: 6373753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of protease nexin-1 target protease specificity by collagen type IV.
    Donovan FM; Vaughan PJ; Cunningham DD
    J Biol Chem; 1994 Jun; 269(25):17199-205. PubMed ID: 8006028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of protease nexin-1 to the fibroblast surface alters its target proteinase specificity.
    Wagner SL; Lau AL; Cunningham DD
    J Biol Chem; 1989 Jan; 264(1):611-5. PubMed ID: 2642483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease nexin 1 is a potent urinary plasminogen activator inhibitor in the presence of collagen type IV.
    Crisp RJ; Knauer MF; Knauer DJ
    J Biol Chem; 2002 Dec; 277(49):47285-91. PubMed ID: 12356769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of extracellular plasminogen activator by human fibroblasts. The role of protease nexin.
    Scott RW; Eaton DL; Duran N; Baker JB
    J Biol Chem; 1983 Apr; 258(7):4397-403. PubMed ID: 6339496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin on adherent cells: from microvesiculation to apoptosis.
    Doeuvre L; Plawinski L; Goux D; Vivien D; Anglés-Cano E
    Biochem J; 2010 Dec; 432(2):365-73. PubMed ID: 20846121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the heparin and low density lipid receptor-related protein-binding sites of protease nexin 1 (PN1) in urokinase-PN1 complex catabolism. The PN1 heparin-binding site mediates complex retention and degradation but not cell surface binding or internalization.
    Crisp RJ; Knauer DJ; Knauer MF
    J Biol Chem; 2000 Jun; 275(26):19628-37. PubMed ID: 10867020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis.
    Horowitz JC; Rogers DS; Simon RH; Sisson TH; Thannickal VJ
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):78-87. PubMed ID: 17656680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR; De Cock F; Collen D
    Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation.
    Hägglund AC; Ny A; Liu K; Ny T
    Endocrinology; 1996 Dec; 137(12):5671-7. PubMed ID: 8940398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericellular plasmin induces smooth muscle cell anoikis.
    Meilhac O; Ho-Tin-Noé B; Houard X; Philippe M; Michel JB; Anglés-Cano E
    FASEB J; 2003 Jul; 17(10):1301-3. PubMed ID: 12738809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activators and inhibitors in the neuromuscular system: III. The serpin protease nexin I is synthesized by muscle and localized at neuromuscular synapses.
    Festoff BW; Rao JS; Hantaï D
    J Cell Physiol; 1991 Apr; 147(1):76-86. PubMed ID: 2037625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease nexin I, thrombin- and urokinase-inhibiting serpin, concentrated in normal human cerebrospinal fluid.
    Festoff BW; Rao JS; Chen M
    Neurology; 1992 Jul; 42(7):1361-6. PubMed ID: 1620346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans.
    Sashindranath M; Sales E; Daglas M; Freeman R; Samson AL; Cops EJ; Beckham S; Galle A; McLean C; Morganti-Kossmann C; Rosenfeld JV; Madani R; Vassalli JD; Su EJ; Lawrence DA; Medcalf RL
    Brain; 2012 Nov; 135(Pt 11):3251-64. PubMed ID: 22822039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate expression of anticoagulant heparan sulfate proteoglycans and serine protease inhibitors in the rat ovary: a potent system of proteolysis control.
    Hasan S; Hosseini G; Princivalle M; Dong JC; Birsan D; Cagide C; de Agostini AI
    Biol Reprod; 2002 Jan; 66(1):144-58. PubMed ID: 11751276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of serine proteinase inhibitors on bone resorption in vitro.
    Tumber A; Papaioannou S; Breckon J; Meikle MC; Reynolds JJ; Hill PA
    J Endocrinol; 2003 Sep; 178(3):437-47. PubMed ID: 12967336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X; Chaudhry A; Chintala SK
    Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.